GlassScriptPhysician profile
Cassidy Lowman
NPI 1518846138
$406.06
in general payments reported to CMS, 2019-2025
12 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $406.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $108.14 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.64 | 2025 | Lifevest |
| Abbott Laboratories | $52.28 | 2025 | Triclip |
| Bayer Healthcare Pharmaceuticals INC. | $44.87 | 2025 | |
| Heartflow, INC. | $22.21 | 2025 | |
| Scpharmaceuticals INC. | $20.41 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $19.87 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $17.52 | 2025 | Wainua |
| Merck Sharp & Dohme LLC | $17.13 | 2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $16.23 | 2025 | |
| Bridgebio Pharma, INC. | $16.12 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $15.64 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassidy Lowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.